Abstract
The vacuolar protein sorting 35 (VPS35) gene located on chromosome 16 has recently emerged as a cause of late-onset familial Parkinson’s disease (PD) (PARK17). The gene encodes a 796-residue protein nearly ubiquitously expressed in human tissues. The protein localizes on endosomes where it assembles with other peripheral membrane proteins to form the retromer complex. How VPS35 mutations induce dopaminergic neuron degeneration in humans is still unclear. Because the retromer complex recycles the receptors that mediate the transport of hydrolase to lysosome, it has been suggested that VPS35 mutations lead to impaired lysosomal and autophagy function. Recent studies also demonstrated that VPS35 and the retromer complex influence mitochondrial homeostasis, suggesting that VPS35 mutations elicit mitochondrial dysfunction. More recent studies have identified a key role of VPS35 in neurotransmission, whilst others reported a functional interaction between VPS35 and other genes associated with familial PD, including α-SYNUCLEIN-PARKIN–LRRK2. Here, we review the biological role of VPS35 protein, the VPS35 mutations identified in human PD patients, and the potential molecular mechanism by which VPS35 mutations can induce progressive neurodegeneration in PD.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ando M, Funayama M, Li Y et al (2012) VPS35 mutation in Japanese patients with typical Parkinson’s disease. Mov Disord 27:1413–1417. https://doi.org/10.1002/mds.25145
Arighi CN, Harmell LM, Aguilar RC et al (2004) Role of the mammalian retromer in sorting of the cation-independent mannose 6-phosphate receptor. J Cell Biol. https://doi.org/10.1083/jcb.200312055
Aufschnaiter A, Kohler V, Büttner S (2017) Taking out the garbage: Cathepsin D and calcineurin in neurodegeneration. Neural Regen Res. https://doi.org/10.4103/1673-5374.219031
Birmingham CL, Smith AC, Bakowski MA et al (2006) Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole. J Biol Chem. https://doi.org/10.1074/jbc.M509157200
Blanckenberg J, Ntsapi C, Carr JA, Bardien S (2014) EIF4G1 R1205H and VPS35 D620N mutations are rare in Parkinson’s disease from South Africa. Neurobiol Aging. https://doi.org/10.1016/j.neurobiolaging.2013.08.023
Bonifacino JS, Hurley JH (2008) Retromer. Curr. Opin. Cell Biol 20:427436
Borrageiro G, Haylett W, Seedat S et al (2018) A review of genome-wide transcriptomics studies in Parkinson’s disease. Eur J Neurosci 47:1–16
Braschi E, Goyon V, Zunino R et al (2010) Vps35 mediates vesicle transport between the mitochondria and peroxisomes. Curr Biol. https://doi.org/10.1016/j.cub.2010.05.066
Cataldi S, Follett J, Fox JD et al (2018) Altered dopamine release and monoamine transporters in Vps35 p.D620N knock-in mice. NPJ Park Dis. https://doi.org/10.1038/s41531-018-0063-3
Cha G-H, Kim S, Park J et al (2005) Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila. Proc Natl Acad Sci USA. https://doi.org/10.1073/pnas.0500346102
Chen X, Kordich JK, Williams ET et al (2019) Parkinson’s disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration. Proc Natl Acad Sci USA. https://doi.org/10.1073/pnas.1814909116
Chen YF, Chang YY, Lan MY et al (2017) Identification of VPS35 p.D620N mutation-related Parkinson’s disease in a Taiwanese family with successful bilateral subthalamic nucleus deep brain stimulation: a case report and literature review. BMC Neurol. https://doi.org/10.1186/s12883-017-0972-5
Choy RWY, Park M, Temkin P et al (2014) Retromer mediates a discrete route of local membrane delivery to dendrites. Neuron. https://doi.org/10.1016/j.neuron.2014.02.018
Deng H, Gao K, Jankovic J (2013) The VPS35 gene and Parkinson’s disease. Mov Disord 28:569–575
Deng H, Wang P, Jankovic J (2018) The genetics of Parkinson disease. Ageing Res Rev 42:72–85
Deng H, Xu H, Deng X et al (2012) VPS35 mutation in Chinese Han patients with late-onset Parkinson’s disease. Eur J Neurol 19(9):e96–e97
Deutschländer A, Ross OA, Wszolek ZK (2019) VPS35-related Parkinson disease summary genetic counseling. University of Washington, Seattle, pp 1–17
Dhungel N, Eleuteri S, Li LB et al (2015) Parkinson’s disease genes VPS35 and EIF4G1 interact genetically and converge on α-synuclein. Neuron. https://doi.org/10.1016/j.neuron.2014.11.027
Dickson DW, Fujishiro H, Orr C et al (2009) Neuropathology of non-motor features of Parkinson disease. Park Relat Disord. https://doi.org/10.1016/S1353-8020(09)70769-2
Edgar AJ, Polak JM (2000) Human homologues of yeast vacuolar protein sorting 29 and 35. Biochem Biophys Res Commun. https://doi.org/10.1006/bbrc.2000.3727
Elwell C, Engel J (2018) Emerging role of retromer in modulating pathogen growth. Trends Microbiol 26(9):769–780
Enami S, Sakamoto Y, Colussi AJ (2014) Fenton chemistry at aqueous interfaces. Proc Natl Acad Sci USA. https://doi.org/10.1073/pnas.1314885111
Gagliardi M, Annesi G, Tarantino P et al (2014) Frequency of the ASP620ASN mutation in VPS35 and Arg1205His mutation in EIF4G1 in familial Parkinson’s disease from South Italy. Neurobiol Aging. https://doi.org/10.1016/j.neurobiolaging.2014.04.020
Goedert M, Jakes R, Spillantini MG (2017) The synucleinopathies: twenty years on. J Parkinsons Dis 7:s51–s69
Gorostidi A, Martí-Massó JF, Bergareche A et al (2016) Genetic mutation analysis of Parkinson’s disease patients using multigene next-generation sequencing panels. Mol Diagnosis Ther. https://doi.org/10.1007/s40291-016-0216-1
Guella I, Soldà G, Cilia R et al (2012) The Asp620asn mutation in VPS35 is not a common cause of familial Parkinson’s disease. Mov Disord 27:800–801
Guo JF, Sun QY, Lv ZY et al (2012) VPS35 gene variants are not associated with Parkinson’s disease in the mainland Chinese population. Park Relat Disord. https://doi.org/10.1016/j.parkreldis.2012.05.002
Haft CR, de la Sierra ML, Bafford R et al (2000) Human orthologs of yeast vacuolar protein sorting proteins Vps 26, 29, and 35: assembly into multimeric complexes. Mol Biol Cell. https://doi.org/10.1091/mbc.11.12.4105
Hierro A, Rojas AL, Rojas R et al (2007) Functional architecture of the retromer cargo-recognition complex. Nature. https://doi.org/10.1038/nature06216
Hirayama T, Inden M, Tsuboi H et al (2019) A Golgi-targeting fluorescent probe for labile Fe(ii) to reveal an abnormal cellular iron distribution induced by dysfunction of VPS35. Chem Sci. https://doi.org/10.1039/c8sc04386h
Inoshita T, Arano T, Hosaka Y et al (2017) Vps35 in cooperation with LRRK2 regulates synaptic vesicle endocytosis through the endosomal pathway in Drosophila. Hum Mol Genet. https://doi.org/10.1093/hmg/ddx179
Ishizu N, Yui D, Hebisawa A et al (2016) Impaired striatal dopamine release in homozygous Vps35 D620N knock-in mice. Hum Mol Genet. https://doi.org/10.1093/hmg/ddw279
Kalinderi K, Bostantjopoulou S, Katsarou Z et al (2015) D620N mutation in the VPS35 gene and R1205H mutation in the EIF4G1 gene are uncommon in the Greek population. Neurosci Lett. https://doi.org/10.1016/j.neulet.2015.08.020
Klein C, Hattori N, Marras C (2018) MDSGene: Closing data gaps in genotype-phenotype correlations of monogenic Parkinson’s disease. J Parkinsons Dis 8:s25–s30
Kroemer G, Mariño G, Levine B (2010) Autophagy and the integrated stress response. Mol Cell 40(2):280–293
Kumar KR, Weissbach A, Heldmann M et al (2012) Frequency of the D620N mutation in VPS35 in Parkinson disease. Arch Neurol. https://doi.org/10.1001/archneurol.2011.3367
Lawrence RE, Zoncu R (2019) The lysosome as a cellular centre for signalling, metabolism and quality control. Nat Cell Biol 21(2):133–142
Li C, Shah SZA, Zhao D, Yang L (2016) Role of the retromer complex in neurodegenerative diseases. Front Aging Neurosci 8:42
Linhart R, Wong SA, Cao J et al (2014) Vacuolar protein sorting 35 (Vps35) rescues locomotor deficits and shortened lifespan in Drosophila expressing a Parkinson’s disease mutant of Leucine-rich repeat kinase 2 (LRRK2). Mol Neurodegener. https://doi.org/10.1186/1750-1326-9-23
Lu X-H, Fleming SM, Meurers B et al (2009) Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein. J Neurosci 29:1962–1976. https://doi.org/10.1523/JNEUROSCI.5351-08.2009
Lucas M, Gershlick DC, Vidaurrazaga A et al (2016) Structural mechanism for cargo recognition by the retromer complex. Cell. https://doi.org/10.1016/j.cell.2016.10.056
Lunati A, Lesage S, Brice A (2018) The genetic landscape of Parkinson’s disease. Rev Neurol 174(9):628–643
MacLeod DA, Rhinn H, Kuwahara T et al (2013) RAB7L1 Interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson’s disease risk. Neuron. https://doi.org/10.1016/j.neuron.2012.11.033
Mak SK, McCormack AL, Manning-Bog AB et al (2010) Lysosomal degradation of α-synuclein in vivo. J Biol Chem. https://doi.org/10.1074/jbc.M109.074617
Malik BR, Godena VK, Whitworth AJ (2015) VPS35 pathogenic mutations confer no dominant toxicity but partial loss of function in Drosophila and genetically interact with parkin. Hum Mol Genet 24:6106–6117. https://doi.org/10.1093/hmg/ddv322
Marras C, Canning CG, Goldman SM (2019) Environment, lifestyle, and Parkinson’s disease: Implications for prevention in the next decade. Mov Disord 34(6):806–811
Martinez A, Lectez B, Ramirez J et al (2017) Quantitative proteomic analysis of Parkin substrates in Drosophila neurons. Mol Neurodegener. https://doi.org/10.1186/s13024-017-0170-3
McGough IJ, Steinberg F, Jia D et al (2014) Retromer binding to FAM21 and the WASH complex is perturbed by the Parkinson disease-linked VPS35(D620N) mutation. Curr Biol. https://doi.org/10.1016/j.cub.2014.06.024
Mir R, Tonelli F, Lis P et al (2018) The Parkinson’s disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human. Biochem J. https://doi.org/10.1042/bcj20180248
Miura E, Hasegawa T, Konno M et al (2014) VPS35 dysfunction impairs lysosomal degradation of α-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson’s disease. Neurobiol Dis. https://doi.org/10.1016/j.nbd.2014.07.014
Mohan M, Mellick GD (2017) Role of the VPS35 D620N mutation in Parkinson’s disease. Park Relat Disord 36:10–18
Munsie LN, Milnerwood AJ, Seibler P et al (2015) Retromer-dependent neurotransmitter receptor trafficking to synapses is altered by the Parkinson’s disease VPS35 mutation pD620N. Hum Mol Genet. https://doi.org/10.1093/hmg/ddu582
Neuspiel M, Schauss AC, Braschi E et al (2008) Cargo-selected transport from the mitochondria to peroxisomes is mediated by vesicular carriers. Curr Biol. https://doi.org/10.1016/j.cub.2007.12.038
Nussbaum RL (2018) Genetics of synucleinopathies. Cold Spring Harb Perspect Med. https://doi.org/10.1101/cshperspect.a024109
Nuytemans K, Bademci G, Inchausti V et al (2013) Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease. Neurology 80:982–989. https://doi.org/10.1212/WNL.0b013e31828727d4
Obeso JA, Stamelou M, Goetz CG (2017) Past, present, and future of Parkinson’s disease: A special essay on the 200th Anniversary of the Shaking Palsy. Mov. Disord 32(9):1264–1310
Paisán-Ruíz C, Jain S, Evans EW et al (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease. Neuron. https://doi.org/10.1016/j.neuron.2004.10.023
Pang SYY, Ho PWL, Liu HF et al (2019) The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson’s disease. Transl Neurodegener 8(1):23
Paravicini G, Horazdovsky BF, Emr SD (1992) Alternative pathways for the sorting of soluble vacuolar proteins in yeast: a vps35 null mutant missorts and secretes only a subset of vacuolar hydrolases. Mol Biol Cell. https://doi.org/10.1091/mbc.3.4.415
Pont-Sunyer C, Hotter A, Gaig C et al (2015) The onset of nonmotor symptoms in Parkinson’s disease (the onset PD study). Mov Disord. https://doi.org/10.1002/mds.26077
Priya A, Kalaidzidis IV, Kalaidzidis Y et al (2015) Molecular Insights into Rab7-mediated endosomal recruitment of core retromer: deciphering the role of Vps26 and Vps35. Traffic. https://doi.org/10.1111/tra.12237
Ravikumar B (2002) Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum Mol Genet. https://doi.org/10.1093/hmg/11.9.1107
Ravikumar B, Vacher C, Berger Z et al (2004) Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet. https://doi.org/10.1038/ng1362
Rojas R, Van Vlijmen T, Mardones GA et al (2008) Regulation of retromer recruitment to endosomes by sequential action of Rab5 and Rab7. J Cell Biol. https://doi.org/10.1083/jcb.200804048
Rui Q, Ni H, Li D et al (2018) The Role of LRRK2 in Neurodegeneration of Parkinson Disease. Curr Neuropharmacol. https://doi.org/10.2174/1570159x16666180222165418
Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18(7):435
Seaman MNJ (2012) The retromer complex-endosomal protein recycling and beyond. J. Cell Sci. 125(20):4693–4702
Seaman MNJ (2005) Recycle your receptors with retromer. Trends Cell Biol 15(2):68–75
Seaman MNJ, Harbour ME, Tattersall D et al (2009) Membrane recruitment of the cargo-selective retromer subcomplex is catalysed by the small GTPase Rab7 and inhibited by the Rab-GAP TBC1D5. J Cell Sci. https://doi.org/10.1242/jcs.048686
Seaman MNJ, Marcusson EG, Cereghino JL, Emr SD (1997) Endosome to Golgi retrieval of the vacuolar protein sorting receptor, Vps10p, requires the function of the VPS29, VPS30, and VPS35 gene products. J Cell Biol. https://doi.org/10.1083/jcb.137.1.79
Seaman MNJ, McCaffery JM, Emr SD (1998) A membrane coat complex essential for endosome-to-Golgi retrograde transport in yeast. J Cell Biol. https://doi.org/10.1083/jcb.142.3.665
Sharma M, Ioannidis JPA, Aasly JO et al (2012) A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants. J Med Genet 49:721–726. https://doi.org/10.1136/jmedgenet-2012-101155
Sheerin UM, Charlesworth G, Bras J et al (2012) Screening for VPS35 mutations in Parkinson’s disease. Neurobiol Aging 33:838.e1–838.e5. https://doi.org/10.1016/j.neurobiolaging.2011.10.032
Sims NA (2016) VPS35: two ways to recycle the parathyroid hormone receptor (PTH1R) in Osteoblasts. EBioMedicine 9:3–4
Sudhaman S, Behari M, Govindappa ST et al (2013) VPS35 and EIF4G1 mutations are rare in Parkinson’s disease among Indians. Neurobiol Aging. https://doi.org/10.1016/j.neurobiolaging.2013.04.025
Tang FL, Erion JR, Tian Y et al (2015a) VPS35 in dopamine neurons is required for endosome-to- golgi retrieval of Lamp2a, a receptor of chaperone- mediated autophagy that is critical for α-synuclein degradation and prevention of pathogenesis of Parkinson’s disease. J Neurosci. https://doi.org/10.1523/JNEUROSCI.0042-15.2015
Tang FL, Liu W, Hu JX et al (2015b) VPS35 deficiency or mutation causes dopaminergic neuronal loss by impairing mitochondrial fusion and function. Cell Rep 12:1631–1643. https://doi.org/10.1016/j.celrep.2015.08.001
Teasdale RD, Collins BM (2012) Insights into the PX (phox-homology) domain and SNX (sorting nexin) protein families: Structures, functions and roles in disease. Biochem. J 441:39–59
Temkin P, Lauffer B, Jäger S et al (2011) SNX27 mediates retromer tubule entry and endosome-to-plasma membrane trafficking of signalling receptors. Nat Cell Biol. https://doi.org/10.1038/ncb2252
Tian Y, Tang FL, Sun XD et al (2015) VPS35-deficiency results in an impaired AMPA receptor trafficking and decreased dendritic spine maturation. Mol Brain. https://doi.org/10.1186/s13041-015-0156-4
Török R, Zádori D, Török N et al (2016) An assessment of the frequency of mutations in the GBA and VPS35 genes in Hungarian patients with sporadic Parkinson’s disease. Neurosci Lett. https://doi.org/10.1016/j.neulet.2015.11.001
Tsika E, Glauser L, Moser R et al (2014) Parkinson’s disease-linked mutations in VPS35 induce dopaminergic neurodegeneration. Hum Mol Genet. https://doi.org/10.1093/hmg/ddu178
Varandas KC, Irannejad R, von Zastrow M (2016) Retromer endosome exit domains serve multiple trafficking destinations and regulate local G protein activation by GPCRs. Curr Biol. https://doi.org/10.1016/j.cub.2016.09.052
Vazquez-Sanchez S, Bobeldijk S, Dekker MP et al (2018) VPS35 depletion does not impair presynaptic structure and function. Sci Rep. https://doi.org/10.1038/s41598-018-20448-4
Venderova K, Kabbach G, Abdel-Messih E et al (2009) Leucine-rich repeat kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson’s disease. Hum Mol Genet. https://doi.org/10.1093/hmg/ddp394
Verstraeten A, Wauters E, Crosiers D et al (2012) Contribution of VPS35 genetic variability to LBD in the Flanders-Belgian population. Neurobiol Aging 33:1844.e11–1844.e13. https://doi.org/10.1016/j.neurobiolaging.2012.01.006
Vilariño-Güell C, Wider C, Ross OA et al (2011) VPS35 mutations in parkinson disease. Am J Hum Genet 89:162–167. https://doi.org/10.1016/j.ajhg.2011.06.001
Wang W, Wang X, Fujioka H et al (2016) Parkinson’s disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes. Nat Med. https://doi.org/10.1038/nm.3983
Webb JL, Ravikumar B, Atkins J et al (2003) α-synuclein Is Degraded by Both Autophagy and the Proteasome. J Biol Chem. https://doi.org/10.1074/jbc.M300227200
Wen L, Tang FL, Hong Y et al (2011) VPS35 haploinsufficiency increases Alzheimer’s disease neuropathology. J Cell Biol. https://doi.org/10.1083/jcb.201105109
Wider C, Skipper L, Solida A et al (2008) Autosomal dominant dopa-responsive parkinsonism in a multigenerational Swiss family. Park Relat Disord. https://doi.org/10.1016/j.parkreldis.2007.11.013
Williams ET, Chen X, Moore DJ (2017) VPS35, the retromer complex and Parkinson’s disease. J Parkinsons Dis 7:219–233
Williams ET, Glauser L, Tsika E et al (2018) Parkin mediates the ubiquitination of VPS35 and modulates retromer-dependent endosomal sorting. Hum Mol Genet. https://doi.org/10.1093/hmg/ddy224
Xilouri M, Brekk OR, Stefanis L (2013) α-Synuclein and protein degradation systems: a reciprocal relationship. Mol Neurobiol 47:537–551
Yang Z, Hong LK, Follett J et al (2016) Functional characterization of retromer in GLUT4 storage vesicle formation and adipocyte differentiation. FASEB J. https://doi.org/10.1096/fj.15-274704
Yin J, Liu X, He Q et al (2016) Vps35-dependent recycling of Trem2 regulates microglial function. Traffic. https://doi.org/10.1111/tra.12451
Zavodszky E, Seaman MNJ, Moreau K et al (2014) Mutation in VPS35 associated with Parkinson’s disease impairs WASH complex association and inhibits autophagy. Nat Commun. https://doi.org/10.1038/ncomms4828
Zhang P, Yu L, Gao J et al (2000) Cloning and characterization of human VPS35 and mouse Vps35 and mapping of VPS35 to human chromosome 16q13-q21. Genomics. https://doi.org/10.1006/geno.2000.6380
Zhang Y, Chen S, Xiao Q et al (2012) Vacuolar protein sorting 35 Asp620Asn mutation is rare in the ethnic Chinese population with Parkinson’s disease. Park Relat Disord. https://doi.org/10.1016/j.parkreldis.2012.02.011
Zimprich A, Benet-Pagès A, Struhal W et al (2011) A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset parkinson disease. Am J Hum Genet 89:168–175. https://doi.org/10.1016/j.ajhg.2011.06.008
Author information
Authors and Affiliations
Contributions
JS had the idea for the article and drafted it. JS, CR, GD, and MR performed the literature search and data analysis. MTP and BG critically revised the work. All authors reviewed and approved the manuscript for publication.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Research Involving Human Participants and Animals
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sassone, J., Reale, C., Dati, G. et al. The Role of VPS35 in the Pathobiology of Parkinson’s Disease. Cell Mol Neurobiol 41, 199–227 (2021). https://doi.org/10.1007/s10571-020-00849-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-020-00849-8